Tyler Garretson

Assoc Director @GSK Vaccines. Former @Pfizer Vaccines, PD @PennMicro, PhD @miamiuniversity. Vinyl record junkie, slow runner. Opinions are my own. (he/his/him)

[Tyler Garretson @tgarretson82]

Excited to see this work out in preprint. Can’t thank Scott enough for the opportunity to be apart of this project. The Hensley lab and Penn Microbiology is a highly innovative and collaborative environment for any training. Can’t recommend enough to early career scientists.

[Hensley Lab @SCOTTeHENSLEY]

I’m excited to see our paper posted @medrxivpreprint showing that older folks have higher levels of antibodies that recognize H5N1 viruses compared to younger individuals. Finally some good news for old people. 1/12 https://t.co/YZWLt98rgu

[Hensley Lab @SCOTTeHENSLEY]

I’m excited to see our paper posted @medrxivpreprint showing that older folks have higher levels of antibodies that recognize H5N1 viruses compared to younger individuals. Finally some good news for old people. 1/12 https://t.co/YZWLt98rgu

[Bloom Lab @jbloom_lab]

Here is analysis of HA mutations in H5 influenza case in Missouri resident without known contact w animals or raw milk.

TLDR: there is one HA mutation that strongly affects antigenicity, and another that merits some further study.

[The Bjorkman Lab @bjorkmanlab]

It's paper season in the Bjorkman Lab! Read more about the next-generation pan-sarbecovirus vaccine candidate developed in the Bjorkman lab in our latest publication in @CellCellPress
https://t.co/2KMioKdZ7H

[Bloom Lab @jbloom_lab]

In new study led by @bdadonaite, we measure how all mutations to H5 influenza HA affect four molecular phenotypes relevant to pandemic risk:
https://t.co/QOjVTF4h9L

Results can inform surveillance of ongoing evolution of H5N1.

[Tyler Garretson @tgarretson82]

Startling study. The scale and impact of microplastics on human health needs MUCH more research.

[Eric Topol @EricTopol]

The new Ground Truths is on a very concerning @NEJM prospective multicenter study today
2 big firsts:
1. Micro/nano plastics found in majority (58%) of patient carotid artery atherosclerotic plaques
2. Carried a 4.5 fold increased risk of major adverse outcomes
[link in profile]

[Helen Branswell 🇨🇦 @HelenBranswell]

1. Canadian researchers publish the first estimates of 2023-24 #flu vaccine effectiveness that I've seen to date, in @Eurosurveillanc. The VE is pretty good — 61% overall against H1N1, which was responsible for the vast majority of cases. https://t.co/jnjA5TG70m

[Tyler Garretson @tgarretson82]

I’m going to test out Mastodon.
@[email protected]

[Tyler Garretson @tgarretson82]

Important data with potentially big implications. Highlights the need for more research into the link between herpesviruses and neurological disorders.

[Pascal Geldsetzer @PGeldsetzer1]

Biggest thing to ever come out of my little group. Pls help spread this finding!

We found clean, CAUSAL evidence that the shingles vaccine prevents a good chunk of dementia cases. So, could a virus cause Alzheimer’s->YES!

Hear me out & see preprint: https://t.co/25f5XFQj8R
🧵1/

[NEJM @NEJM]

Respiratory syncytial virus causes clinically significant illness in children and adults. In a placebo-controlled trial, a prefusion stabilized F protein vaccine led to an 83% lower risk of RSV infection. https://t.co/aU9BV0LXBU

[Cell Host & Microbe @cellhostmicrobe]

Rethinking next-generation vaccines for #coronaviruses, #influenza viruses, & other respiratory viruses. Morens, Taubenberger, Fauci @NIAIDNews discuss approaches that need to be prioritized for development of vaccines against these viruses https://t.co/DQYnSAL0uz

[Duo Xu @duoxu1989]

Excited to share this recent work on vaccine design via antigen reorientation! https://t.co/SqaQvChkCf

[Penn Medicine @PennMedicine]

.@TheAtlantic's "10 Most Promising Breakthrough Innovations of 2022" includes the development of an experimental, universal #fluvaccine, led by Penn Medicine's @SCOTTeHENSLEY https://t.co/Nkqjivnsbk

[Hensley Lab @SCOTTeHENSLEY]

We developed a new multivalent mRNA vaccine against all known influenza virus subtypes. Our study describing the vaccine was just published in @ScienceMagazine. 1/n
https://t.co/HxTKm47EC3

[Eric Topol @EricTopol]

Just published @ScienceMagazine
A universal influenza mRNA vaccine effective against all 20 lineages of influenza A and B, effective in experimental models
https://t.co/CfABwuE2O0
https://t.co/hyA6lktAgX

[The Late Show @colbertlateshow]

Dr. Fauci was eligible for his COVID booster shot so Stephen took him next door to the pharmacy to get vaccinated — and they had quite the journey.

#Colbert

[John Paget, PhD @PagetPhd]

Major influenza A (H3) epidemic underway in Australia

▶️ This may be a sign of things to come in Europe during the 2022/23 winter

[Tyler Garretson @tgarretson82]

@SCOTTeHENSLEY @CAMBUpenn Congrats, Dr Bolton!

[Nature Microbiology @NatureMicrobiol]

OUT NOW:Early-life viral infections are associated with disadvantageous immune and #microbiota profiles and recurrent respiratory infections
By Bogaert & co @wsteenhu1 @DebbyBogaert @Bogaert_group @UMCUtrecht

Read it here: https://t.co/HdcCk3GGHt
https://t.co/AksWGYM8Uc

[Tyler Garretson @tgarretson82]

@SCOTTeHENSLEY @IGGPenn @pennbgs @PennMedicine Congrats, Claudia!